跳至主要内容
临床试验/DRKS00032149
DRKS00032149招募中不适用

Analysis of coagulation factor XIII as a predictor of postoperative complications after reconstructive surgery in patients following massive weight loss. - FXIIIinWHO

Marien Hospital Witten0 个研究点目标入组 168 人开始时间: 2023年7月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
168

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Initially, all patients should have had a body mass index (BMI) of = 40 kg/m² and currently have a BMI below 35 kg/m² for the planned surgery.
  • Patients in the control group
  • Upper extremity fracture (excluding carpus or hand fractures) and a stable BMI of < 35 kg/m² in the past 12 months (no changes of 5% or more in body weight). In differentiation from the first group, these must not have had a BMI of = 40 kg/m² in the past.

排除标准

  • - Patients during pregnancy and lactation
  • - Hypersensitivity to the active substance factor XIII
  • - Hypersensitivity to heparin
  • - Known coagulation disorder
  • - Current anticoagulation
  • - Termination of anticoagulation less than 6 months ago

研究者

发起方
Marien Hospital Witten

相似试验